13 July 2026
Telehealth GLP-1 prescribing practices may expose patients to unsafe care, weak medical checks and compounded weight-loss drugs.
9 February 2026
3 February 2026
Roche CT-388 Obesity Drug shows up to 22.5% placebo-adjusted weight loss at 48 weeks, as Roche moves into Phase 3 to challenge Lilly and Novo.
24 November 2025
Eli Lilly hits $1 trillion valuation, marking a historic milestone in the pharmaceutical industry with successful weight-loss drugs.
11 November 2025
The landmark obesity drug deal announced by Trump aims to make weight management drugs more affordable for millions of patients.
26 August 2025
Find out how GLP-1 drugs like Ozempic and Wegovy can lower cancer risk while aiding in weight loss and diabetes control.
22 August 2025
Novo Nordisk implements a hiring freeze as layoffs approach after Wegovy's success. Discover the impact on the pharmaceutical industry.
29 June 2025
Orforglipron can offer a new oral option for managing weight loss and blood sugar in type 2 diabetes treatment.
24 October 2024
Novo Nordisk's share price dropped 19% amidst growing competition from Eli Lilly in the diabetes and weight-loss drug market.